Related references
Note: Only part of the references are listed.Osteocyte control of osteoclastogenesis
Charles A. O'Brien et al.
BONE (2013)
RANKL Cytokine: From Pioneer of the Osteoimmunology Era to Cure for a Rare Disease
Nadia Lo Iacono et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
A RANKL G278R mutation causing osteopetrosis identifies a functional amino acid essential for trimer assembly in RANKL and TNF
Eleni Douni et al.
HUMAN MOLECULAR GENETICS (2012)
An activating Fgfr3 mutation affects trabecular bone formation via a paracrine mechanism during growth
Emilie Mugniery et al.
HUMAN MOLECULAR GENETICS (2012)
Osteopetrosis Rescue Upon RANKL Administration to Rankl-/- Mice: A New Therapy for Human RANKL-Dependent ARO
Nadia Lo Iacono et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Crystal Structure of Human RANKL Complexed with Its Decoy Receptor Osteoprotegerin
Xudong Luan et al.
JOURNAL OF IMMUNOLOGY (2012)
Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody
Paul J. Kostenuik et al.
BONE (2011)
Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys
Michael S. Ominsky et al.
BONE (2011)
Quantification of Vertebral Bone Marrow Fat Content Using 3 Tesla MR Spectroscopy: Reproducibility, Vertebral Variation, and Applications in Osteoporosis
Xiaojuan Li et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2011)
RANKL/RANK-beyond bones
Reiko Hanada et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
PKA-induced Receptor Activator of NF-κB Ligand (RANKL) Expression in Vascular Cells Mediates Osteoclastogenesis but Not Matrix Calcification
Wendy Tseng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Bone, Fat, and Body Composition: Evolving Concepts in the Pathogenesis of Osteoporosis
Clifford J. Rosen et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Inhibition of Receptor Activator of NF-κB Ligand by Denosumab Attenuates Vascular Calcium Deposition in Mice
Susann Helas et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin
Xiaodong Li et al.
BONE (2009)
Denosumab, a Fully Human Monoclonal Antibody to RANKL, Inhibits Bone Resorption and Increases BMD in Knock-In Mice That Express Chimeric (Murine/Human) RANKL
Paul J. Kostenuik et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
Matthew R. Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Steven R. Cummings et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Generating transgenic mice from bacterial artificial chromosomes: transgenesis efficiency, integration and expression outcomes
Margaret L. Van Keuren et al.
TRANSGENIC RESEARCH (2009)
RANK/RANKL: Regulators of Immune Responses and Bone Physiology
Andreas Leibbrandt et al.
YEAR IN IMMUNOLOGY 2008 (2008)
Downregulation of β-catenin and transdifferentiation of human osteoblasts to adipocytes under estrogen deficiency
Clara Foo et al.
GYNECOLOGICAL ENDOCRINOLOGY (2007)
Age-dependent change in the 3D structure of cortical porosity at the human femoral midshaft
David M. L. Cooper et al.
BONE (2007)
Mechanisms of disease: is osteoporosis the obesity of bone?
CJ Rosen et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)
Ovariectomy-induced bone loss varies among inbred strains of mice
ML Bouxsein et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo
R Dacquin et al.
JOURNAL OF CELL BIOLOGY (2004)
Receptor activator of nuclear factor kappa B ligand and osteoprotegerin regulate aortic valve calcification
JJ Kaden et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
Role of RANK ligand in mediating increased bone resorption in early postmenopausal women
G Eghbali-Fatourechi et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Reaching a genetic and molecular understanding of skeletal development
G Karsenty et al.
DEVELOPMENTAL CELL (2002)
Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis
A Mizuno et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2002)
Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene
N Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo
DL Lacey et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)